Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
Trivioli G, Terrier B, Vaglio A.
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii84-iii94. doi: 10.1093/rheumatology/kez570.
PMID:32348510
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.
Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, Magee T, Piligian B, Yoon P, Ellis JH, Sun X, Panch SR, Powers A, Alao H, Kumar S, Quezado M, Yan L, Lee N, Kolbeck R, Newbold P, Goldman M, Fay MP, Khoury P, Maric I, Klion AD.
N Engl J Med. 2019 Apr 4;380(14):1336-1346. doi: 10.1056/NEJMoa1812185.
PMID:30943337
Eosinophils and eosinophilic immune dysfunction in health and disease.
Jackson DJ, Akuthota P, Roufosse F.
Eur Respir Rev. 2022 Jan 25;31(163):210150. doi: 10.1183/16000617.0150-2021. Print 2022 Mar 31.
PMID:35082127
Hypereosinophilic syndromes.
Kahn JE, Blétry O, Guillevin L.
Best Pract Res Clin Rheumatol. 2008 Oct;22(5):863-82. doi: 10.1016/j.berh.2008.09.010.
PMID:19028368
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y.